Across its top 20 institutional holders, ABEV's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 9/100, avg. turnover score 26/100).

Quarterly Activity

Recent Activity

+$2.4B

Total Buy Value

$754.7M

Total Sell Value

New buy62

Trim102

Add161

Sold out33

223

Net Buyers

135

Net Sellers

Smart Money Convergence

ABEV does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

02319V103, 02319v103

FAQ

Who are the top institutional investors holding AMBEV SA-ADR (ABEV)?

Major stakeholders currently include First Eagle Investment Management, LLC ($1.0B), GQG Partners LLC ($546.1M), BlackRock, Inc. ($102.0M). Based on the latest 13F filings, there are a total of 402 tracked investment funds and institutions maintaining positions in ABEV.

What is the overall institutional sentiment toward ABEV recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $467.1M, driven by 223 managers accumulating shares while 135 reduced their exposure.

Which institutions have been selling or reducing their ABEV positions?

In the latest period, 102 funds trimmed their holdings, and 33 managers completely exited their positions. The aggregate reported sell value was $754.7M.

Are there any notable investors adding ABEV to their portfolios?

Yes, buying activity remains notable. 62 institutions opened new positions in {ticker}, and 161 existing holders added to their shares. The total reported buy value for the quarter amounted to $2.4B.